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Abstract 
Cells have been identified in post-natal tissues that when isolated from multiple mesenchymal 
compartments, can be stimulated in vitro to give rise to cells that resemble mature mesenchymal 
phenotypes such as odontoblasts, osteoblasts, adipocytes and myoblasts. This has made these adult 
cells, collectively called mesenchymal stem cells (MSCs), strong candidates for fields such as tissue 
engineering and regenerative medicine. Based on evidence from in vivo genetic lineage tracing 
studies, pericytes have been identified as a source of MSC precursors in vivo in multiple organs, in 
response to injury or during homeostasis. Questions of intense debate and interest in the field of 
tissue engineering and regenerative studies, are 1. Are all pericytes, irrespective of tissue of isolation, 
equal in their differentiation potential? 2. What are the mechanisms that regulate the differentiation 
of MSCs?  To gain a better understanding of the latter, recent work has utilised ChIP-seq to reconstruct 
histone landscapes. This indicated that for dental pulp pericytes the odontoblast specific gene Dspp 
was found in a transcriptionally permissive state, whilst in bone marrow pericytes the osteoblast 
specific gene Runx2 was primed for expression. RNA-seq was also utilised to further characterise the 
two pericyte populations and results highlighted that dental pulp pericytes are already pre-committed 
to an odontoblast fate based on enrichment analysis done indicating over-representation of key 
odontogenic genes. Furthermore, a ChIP-seq experiment on the PRC1 component RING1B indicated 
that this complex is likely involved in inhibiting inappropriate differentiation as it localised to a number 
of loci of key transcription factors that are needed for the induction of adipogenesis, chondrogenesis 
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or myogenesis. In this review we highlight recent data elucidating molecular mechanisms that indicate 
pericytes can be tissue specific pre - committed MSC precursors in vivo and that this pre-commitment 
is a major driving force behind MSC differentiation.  
Keywords: pericytes, stem cells, plasticity, regeneration, epigenetics, mesenchymal stem cell, 
perivascular stem cell, mesenchymal stromal cell, tissue repair 
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Introduction 
 
Mesenchymal stem cells (MSCs) is the generic name (rightly or wrongly), commonly used to describe 
cells isolated from connective tissues (stroma), that in vitro exhibit properties of stem cells. The 
prototypical MSC described almost three decades ago, resides within bone marrow (Caplan 1991; 
Friedenstein et al. 1974; Pittenger et al. 1999). Since then, cells with similar immunophenotype (in 
vivo and in vitro), molecular, and functional properties have been described in multiple organs, 
including teeth  (Gronthos et al. 2002; Gronthos et al. 2000; Miura et al. 2003; Sonoyama et al. 2008), 
dermis  (Toma et al. 2001), adipose  (Zuk et al. 2002), and muscle (Dellavalle et al. 2011). Functional 
(in vitro) characteristics include: their adherence to tissue culture plastic (Pittenger et al. 1999; Zhu et 
al. 2010), morphological similarity, multipotency and tri-lineage differentiation into mesodermal 
lineages including chondrocytes, adipocytes and osteoblasts when stimulated with a cocktail of factors  
(Beltrami et al. 2007; Covas et al. 2008; Huang et al. 2009). While the field was intensely focused on 
studying and exploiting the in vitro characteristics of MSCs, much less attention has been paid to 
identifying their in vivo origin, although certain observations have provided some important clues.  To 
paraphrase Murray et al, there has been great focus on multipotency and tissue engineering and 
repair, but the native origin and physiological roles of MSCs in vivo have been greatly overlooked. The 
 3 
in vivo counterpart of culture expanded MSCs remained largely unknown for many tissues (Murray et 
al. 2014).  
Connective tissues (stroma), exist throughout the body and this suggests that their precursors are 
locally available in multiple tissues where they can act as a source of MSCs for homeostatic 
maintenance and repair of these structures. This would  explain why MSCs can be isolated from almost 
all tissues  (Bianco et al. 2001; Crisan et al. 2008a; Farrington-Rock et al. 2004; Shi and Gronthos 2003). 
In the late 1800s, a contractile cell population residing around capillaries was described by Charles 
Benjamin Rouget  (Rouget 1873). These Rouget cells were then renamed by Karl Zimmermann to what 
today we refer to as pericytes  (Zimmermann 1923), to better describe their perivascular location in 
close association with blood vessels. When considering their cell surface marker profiles, pericytes 
express many MSC “markers” (in vivo and in vitro) CD90, CD73, CD105 and CD44. In addition, other 
markers such as CD146,  smooth muscle actin (SMA), neural glial antigen 2 (NG2) and platelet 
derived growth factor receptor  (PDGFR-β) have been associated with pericytes in multiple human 
and mouse organs including pancreas, placenta, skeletal muscle and adipose tissue (Caplan 2008; 
Crisan et al. 2008b). Pericytes isolated using these markers can give rise to adipocyte-like, osteoblast-
like and chondrocyte-like cells in vitro using tailored tissue culture conditions (Caplan 2008; Crisan et 
al. 2012; Crisan et al. 2008a; Doherty et al. 1998). This has resulted in more similarities being identified 
between MSCs and pericytes (reviewed extensively in : Caplan et al. 2008, and Feng et al. 2010 ) 
leading many researchers to an acceptance that in most tissues, pericytes are precursors of MSCs  
(Covas et al. 2008; Schwab and Gargett 2007). A further source of evidence for this came from the 
observation that typical MSC cultures were capable of being established using blood vessels alone  
(Caplan 2007). Genetic lineage tracing studies performed using a number of Cre-recombinase mouse 
lines is providing in vivo evidence, showing that pericytes can give rise to mature MSC progenitors 
such as odontoblasts  (Feng et al. 2011), osteoblasts (Supakul et al. 2019), and myoblasts  (Dellavalle 
et al. 2007) (Figure 1). A question that remains unanswered however, is how a widely distributed 
differentiated cell type, a pericyte, can give rise to MSCs that will differentiate into tissue-specific cell 
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types depending on the tissue where they are located. Is this a result of niche originating signals or 
mechanisms more intrinsic that regulate appropriate choice of cell fate (Feng et al. 2010)? 
Evidence of MSC pre-programming 
Although MSCs from many tissues can differentiate into osteoblast-like cells, chondrocyte-like cells 
and adipocyte-like cells in vitro, they do not do this in vivo during homeostasis. Although a multipotent 
MSC may exist, no single cell has been definitively described that forms these three differentiated cell 
types in vivo. Several cell populations have been described that can undergo a form of multi-lineage 
differentiation ex vivo, but single cell lineage tracing in vivo is needed to definitively prove the 
existence of a multipotent stem cell  (Chan et al. 2018; Mizuhashi et al. 2018). 
Most MSCs when expanded in vitro show a certain homogeneity in their morphology, cell surface 
antigen profile, and differentiation potential when stimulated (Beltrami et al. 2007; Covas et al. 2008; 
Huang et al. 2009) . It has however, always been recognised that MSCs derived from a wide range of 
tissues are inherently different as suggested by in vitro experiments. Depending on where the cells 
are sourced from, they vary in their colony forming efficiency (Peng et al. 2008), their ability to 
influence the immune system  (Hegyi et al. 2010), and most importantly their potential to differentiate 
down certain mesodermal lineages. MSCs sourced from umbilical cord blood are unable to 
differentiate into adipocytes (Peng et al. 2008) or myoblasts (Sacchetti et al. 2016). Conflicting reports 
exist with regards adipose derived MSCs and their ability to differentiate down osteogenic lineages 
(Azzaz et al. 2014; Covas et al. 2008; James et al. 2012a; James et al. 2012b; James et al. 2012c). It is 
likely that the outcomes of these experiments are context dependent on the adipose tissue depot 
used. What is clear from our observations and that from others such as Sacchetti et al (2016), is that 
pericytes are most likely to yield cells appropriate to the tissue compartment from where they were 
isolated. It is important to note that the vast majority of experiments performed on MSCs describing 
their multipotency, have been carried out with cells propagated in vitro. This could impact the 
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behaviour and innate plasticity of these cells. Therefore, more focus should be placed on studies 
where a strong emphasis is placed on observing these cells as close to their in vivo context as possible. 
What we have observed is that mechanisms for faithful propagation of the appropriate lineage 
identity are established in these cells in vivo (Figure 2). To investigate these mechanisms, we isolated 
pericytes from mouse incisor and long bone. The selection of these cells was based on their proven 
ability to differentiate into two different mineralised cell types (odontoblasts and osteoblasts 
respectively) and also their different embryonic derivation, cranial neural crest and pulp  mesoderm 
respectively  (Arthur et al. 2008; Dennis and Charbord 2002). 
Isolated pericytes were profiled using a number of next generation sequencing (NGS) approaches, 
including RNA sequencing (RNA-Seq) and chromatin immunoprecipitation followed by sequencing 
(ChIP-Seq), to reveal extensive differences in the transcriptomes and histone landscapes of these cells 
(Yianni and Sharpe 2018).    What emerged was that fresh pericytes from tooth pulp and long bone 
marrow shared expression of genes relating to homeostatic processes and those involved in physical 
(adhesion) and molecular (signalling) interactions with the underlying vasculature. Epigenomic 
profiling revealed that the majority of genes in transcriptionally active chromatin regions, identified 
by the abundance for trimethylation of lysine 4 on histone 3 (H3K4me3) (Dennis et al. 2003; Karlić et 
al. 2010; Zhang et al. 2015) were shared between both pericyte populations and were statistically 
enriched for genes involved in regulation and maintenance of cell adhesion. The majority of the genes 
found in these H3K4me3 regions were confirmed to be actively expressed by RNA-seq profiling, this 
being a reflection of these pericytes attachment to blood vessels.   Focusing on gene expression 
differences between the two populations, a gene set enrichment (GSEA) analysis (Subramanian et al. 
2005)unexpectedly revealed that dental pulp residing pericytes were enriched for a number of genes 
involved in odontogenesis. The most striking feature in these incisor pericytes is a low baseline 
expression of Dspp, a gene expressed in odontoblasts, a highly specialised cell type that can 
differentiate from pericytes. This was also evident when interrogating the Dspp locus for the 
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prevalence of a transcriptionally permissive or repressive histone environment. Incisor pericytes 
possessed a sharp peak of H3K4me3 at the transcription start site (TSS) of Dspp, while their bone 
marrow counterparts did not. Mouse incisors grow rapidly, (1.0 mm in 2 days) (An et al. 2018) and the 
transcriptionally open state of chromatin at the promoter of Dspp is indicative of a stem cell primed 
to differentiate. In the BM pericyte RNA-seq datasets we did not detect significant expression of genes 
relating to osteoblast specification. However when investigating the epigenetic landscapes of these 
BM pericytes we found that the promoter of the Runx2 transcription factor,  which is the master 
regulator and first step towards osteoblast differentiation (Gaur et al. 2005; James 2013) was in a 
bivalent state. This locus was abundant in both active and repressive histone post translational 
modifications as shown by ChIP-seq (Yianni and Sharpe 2018) (Figure 3). This observation is intriguing, 
since it is known that bivalent promoters mark genes that are poised for activation should the cognate 
upstream regulator (e.g a transcription factor) or stimulating signal become available  (Bernstein et al. 
2006; Dennis et al. 2003; Gan et al. 2007). This prompted further investigation into the epigenetic 
status of master regulators governing commitment for myogenesis, chondrogenesis and adipogenesis. 
To do this we performed a ChIP-seq experiment to identify the genomic binding sites for the catalytic 
subunit of polycomb repressor complex 1 (PRC1), RING1B. RING1B is  an E3-ubiquitin ligase which 
allows PRC1 to polyubiquitinate lysine 119 of histones H2A (H2Aub119) (Stock et al. 2007). This causes 
further compaction of that genomic locus and predominantly leads to stable repression of genes 
within that locus due to a number of reasons, including physical exclusion of transcription factors from 
subsequent binding (Ren et al., 2008; van Arensbergen et al., 2013; Vidal, 2009).   (Ren et al. 2008) 
(van Arensbergen et al. 2013) (Vidal 2009)What these datasets revealed was that a number of genes 
necessary to drive pericytes down inappropriate (for their organ) lineages were bound by RING1B and 
repressed. These included Myf5, Pax3 and Myod for myogenesis, Osr1, Runx3, Osr2, Nfib, Scx and Sox9 
for chondrogenesis, and Cebpa and Cebpb for adipogenesis. This highlighted that in vivo, bone marrow 
and incisor pericytes are lineage restricted by previously undescribed mechanisms to give rise to pre-
programmed MSCs that can then differ 
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tiate into organ-specific cell types (Figure 3). An important question this raises is are these epigenetic 
mechanisms a bi-product of niche originating regulatory events, potentially driven by signalling 
cascades, or are these mechanisms innate in the pericytes themselves? To further investigate this, 
FACS isolated pericytes from both incisor pulp and bone marrow were expanded in vitro using basal 
medium lacking any stimulating factors, thereby removing any potential niche - originating signals and 
tailored differentiation cocktails. Total RNA was collected from these cells after 31 days and pericytes 
isolated from incisor pulp were found to have upregulated expression of Dspp, whilst pericytes 
isolated from bone marrow had upregulated expression of Runx2, as compared to their fresh in vivo 
counterparts (Figure 4). These in vitro expanded pericytes did not upregulate marker genes of any 
other mesodermal lineage. This observation indicates that although in vitro these pericytes can be 
driven to produce muscle, mineral or fat, this is a by-product of their exogenous stimulation and not 
their endogenous lineage plasticity. These cells carry an epigenetic and transcriptomic program that 
persists even in culture that restricts them to a particular lineage, in this case enforcing an odontoblast 
or an osteoblast differentiation program respectively (Figure 4). This should not be surprising since ex 
vivo differentiation of bone marrow derived and tooth pulp derived MSCs clearly indicates tissue of 
origin -specific differentiation (Gronthos et al. 2000). This data also accurately mirrors the in vivo 
observations from lineage tracing studies showing the contribution of dental pericytes to odontoblasts 
(Feng et al. 2011; Vidovic et al. 2017)and bone marrow pericytes to osteoblasts  (Supakul et al. 2019) 
and not to other lineages within the same organ.  
A recent study has led to some confusion regarding the role of pericytes as MSC precursors where 
lineage tracing with Tbx18, a gene reported to be expressed by pericytes, showed no evidence of a 
differentiated cell contribution in certain tissues including fat, brain and heart (Guimarães-Camboa et 
al. 2017). In addition to already published comments on this study, our transcriptome datasets show 
no expression of Tbx18 in cells identified as pericytes  (Yianni and Sharpe 2018). 
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It is important to note that researchers outside the mineral biology field have also provided evidence 
indicating that in vivo, pericytes are not plastic, but tissue specific pre-committed precursors of MSCs, 
although the molecular basis of this restriction was not investigated. In a recent study, Sacchetti and 
colleagues (Sacchetti et al. 2016) established MSC cultures from pericytes sourced from tissues 
including bone marrow (BM), skeletal muscle (MU) and perinatal cord blood (CB). These perivascular 
cells were FACS isolated from fresh human tissues with the criteria of being negative for pan-
endothelial and pan-haematopoietic marker but positive for MCAM ( CD34- / CD45- / CD146+ ). These 
cells gave rise to MSC colonies in vitro under basal culture conditions that do not stimulate 
differentiation. Using gene-expression profiling the authors determined the transcriptional signature 
of these cells and performed unsupervised hierarchical clustering and principle component analysis. 
An ANOVA-based analysis determined that these cells are radically divergent from each other in terms 
of the genes they express when comparing the same “MSCs” isolated from different anatomical 
locations. They showed that the MU cells express the lineage specific myogenic transcription factor 
PAX7. Interestingly, BM MSCs express a number of genes associated with haematopoietic support 
something that was also validated in our recent epigenetic studies. Sacchetti et al, noted that the 
pericytes they prospectively isolated ( CD34- / CD45- / CD146+ ) when transplanted heterotopically 
using an osteoconductive carrier, formed bone and also established a haematopoietic 
microenvironment while MU and CB MSCs did not. They further showed that MCAM/CD146 
expressing stromal cells from different human tissues differed radically from their BM counterparts in 
differentiation potency and transcriptional profile, reflective of their different developmental origins. 
While BM derived MSCs/pericytes are natively skeletogenic but not myogenic, muscle derived 
MSCs/Pericytes are inherently myogenic but not natively skeletogenic and represent a subset of cells 
with functional features of satellite cells (Figure. 5) (Sacchetti et al. 2016). Multiple studies 
independently corroborate that MSCs and their precursors, residing in a wide range of tissues, are 
very similar, but they are clearly not identical populations. It was first thought that the tissue specific 
microenvironment could be a likely source of this variation, but evidence highlighted here would argue 
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that this is something intrinsically encoded within the molecular memory of these cells. When 
considering the differentiation capabilities of these cells (based on in vitro studies) it makes biological 
sense that molecular checkpoints would be in place to prevent non-specific differentiation in vivo. It 
could be argued that with age these molecular mechanisms could be perturbed as is suggested in 
tissues of aging patients or experimental animals where  pericytes increasingly contribute to scarring 
and fibrosis as opposed to regeneration and repair (Goritz et al. 2011; Greenhalgh et al. 2013; 
Sundberg et al. 1996). 
Considerations for the future  
Recent publications in the field of MSC biology highlight a number of important concepts that have 
been largely overlooked or understudied. There is a widely shared acceptance that pericytes and MSCs 
are ubiquitous in the mesenchymal compartment of tissues, and regardless of the tissue they are 
sourced from, can be expanded to give a skeletogenic, adipogenic or myogenic phenotypes depending 
on how they are stimulated. Data discussed here clearly demonstrate that these ubiquitous cells differ 
in their in vivo transcriptomes/epigenomes and are not uniform in terms of their lineage commitment: 
they represent subsets of tissue specific lineage committed precursors.  
A number of important points need to be raised; at this stage it is unclear how differences in cell 
surface marker expression might possible mirror functional heterogeneity in vivo. When taking into 
account the total pericyte content of a tissue, one subset of cells might be pre-destined to differentiate 
into mature mesodermal cells while others are confined to functional properties relating to the 
maintenance of the underlying vasculature. Single cell RNA-seq studies are being utilised to better 
understand the population architecture of pericytes within a given organ (He et al. 2018; Tikhonova 
et al. 2019; Zeisel et al. 2018). In the brain for example, single cell transcriptomics has identified three 
different populations of pericytes (Zeisel et al. 2018) 
These studies can be used as a way to design lineage tracing strategies to investigate the contribution 
of these sub-types to other cell types in vivo. Data discussed here have implications for a number of 
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fields including stem cell biology, regeneration, and also tissue engineering. In approaches that require 
the use of MSCs in a scaffold to facilitate repair in vivo, not all sources of primary cells will be 
equivalent in their ability to regenerate the tissue of interest.  
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Figures and Legends: 
 
Figure 1. Pericyte injury/repair response in vivo. In response to injury, or as part of maintaining tissue 
homeostasis, pericytes detach from the blood vessel wall and act as bona fide mesenchymal stem cells 
we will refer to as pMSCs, to distinguish them from MSCs that are not pericyte derived. pMSCs can 
proliferate and move to the area of injury where they differentiate into tissue specific cells to facilitate 
repair.  
  
 15 
 
Figure 2. Pericyte differentiation potential, in vitro and in vivo. In vivo, pericytes have a tissue - 
specific epigenome and a transcriptome that is restricting their differentiation. Upon receiving a 
signal, these pericytes detach and adopt an MSC phenotype that is pre-programmed to give rise to 
cells that will facilitate repair.  In vitro, isolated pericytes will adhere to tissue culture plastic and give 
rise to characteristic looking MSC cultures. These can be directed to differentiate into any 
mesenchymal lineage using tailored stimulating factors that partially alter the inherent 
epigenetic/transcriptomic programs of these cells. As previously shown, if left unstimulated, these 
cells will upregulate lineage specific genes of specialised cells appropriate to their tissue of 
residence(Yianni & Sharpe, 2018).   
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Figure 3.  Lineage priming in vivo. A molecular method has been identified in dental and bone marrow 
pericytes that contributes to organ specific lineage commitment before pericytes detach from the 
basal membrane of blood vessels. In incisor pericytes a transcriptomically permissive chromatin 
structure is in place (high in H3K4me3) that allows transcription of Dspp to take place via the 
recruitment of RNA polymerase II (A). In contrast, while Runx2 is not expressed in bone marrow 
pericytes, we have identified that it is positioned in a bivalent chromatin environment that makes it 
amenable to transcription once the upstream cognate transcription factors become available (B). 
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Figure 4. Lineage Restriction persists in vitro. Fresh pericytes isolated from incisor and long bone will 
readily adhere to tissue culture plastic and give rise to conventional MSC cultures. If they are left to 
proliferate and mature in the absence of stimulating factors, they will upregulate genes for the lineage 
specific to their tissue of origin (A). In contrast, most experiments perturb (or ignore) this innate MSC 
differentiation bias. These cells are driven down non-specific cell lineages by the addition of tailored 
supplements to give rise to mature, terminally differentiated, mesenchymal derivatives. 
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Figure 5. Pericyte MSCs as pre-programmed precursors. Sacchetti et al. isolated pericytes ( CD34- / 
CD45- / CD146+ ) from human bone marrow (BM), post-natal umbilical cord blood (CB), and skeletal 
muscle (MU) which gave rise to traditional MSC cultures in vitro. These MSC cultures could only 
differentiate into bone producing osteoblast or haematopoietic supporting stromal cells if they were 
derived from BM (A). CB MSCs could only be differentiated into chondrocytes (B) and MU MSCs only 
into myoblasts (C).  Adapted from (Sacchetti et al. 2016) 
